Track density imaging in progressive supranuclear palsy: A pilot study.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
15 04 2019
Historique:
received: 18 06 2018
revised: 16 11 2018
accepted: 19 11 2018
pubmed: 27 11 2018
medline: 9 4 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by white matter (WM) changes in different supra- and infratentorial brain structures. We used track density imaging (TDI) to characterize WM microstructural alterations in patients with PSP-Richardson's Syndrome (PSP-RS). Moreover, we investigated the diagnostic utility of TDI in distinguishing patients with PSP-RS from those with Parkinson's disease and healthy controls (HC). Twenty PSP-RS patients, 21 PD patients, and 23 HC underwent a 3 T MRI diffusion-weighted (DW) imaging. Then, we combined constrained spherical deconvolution and WM probabilistic tractography to reconstruct track density maps by calculating the number of WM streamlines traversing each voxel. Voxel-wise analysis was performed to assess group differences in track density maps. A support vector machine (SVM) approach was also used to evaluate the performance of TDI for discriminating between groups. Relative to PD patients, decreases in track density in PSP-RS patients were found in brainstem, cerebellum, thalamus, corpus callosum, and corticospinal tract. Similar findings were obtained between PSP-RS patients and HC. No differences in TDI were observed between PD and HC. SVM approach based on whole-brain analysis differentiated PD patients from PSP-RS with an area under the curve (AUC) of 0.82. The AUC reached a value of 0.98 considering only the voxels belonging to the superior cerebellar peduncle. This study shows that TDI may represent a useful approach for characterizing WM alterations in PSP-RS patients. Moreover, track density decrease in PSP could be considered a new feature for the differentiation of patients with PSP-RS from those with PD.

Identifiants

pubmed: 30474903
doi: 10.1002/hbm.24484
pmc: PMC6865691
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1729-1737

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Références

Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Neurology. 2003 Mar 25;60(6):922-7
pubmed: 12654954
Hum Brain Mapp. 2019 Apr 15;40(6):1729-1737
pubmed: 30474903
Brain. 2005 Jun;128(Pt 6):1247-58
pubmed: 15788542
Neuroradiology. 2008 Nov;50(11):981-5
pubmed: 18779957
Parkinsonism Relat Disord. 2011 Sep;17(8):599-605
pubmed: 21665514
Neuroimage. 2011 Mar 1;55(1):133-41
pubmed: 21147236
Neuroimage. 2011 Feb 1;54(3):2045-51
pubmed: 20828625
Neurology. 2006 Dec 26;67(12):2199-205
pubmed: 17190944
Mov Disord. 2013 Nov;28(13):1816-22
pubmed: 23674400
Arch Neurol. 2011 Jun;68(6):753-60
pubmed: 21670399
J Neurol. 2014 May;261(5):913-24
pubmed: 24599641
Neuroimage. 2010 Dec;53(4):1233-43
pubmed: 20643215
Neurology. 1996 Jul;47(1):1-9
pubmed: 8710059
Neuroimage. 2004 Nov;23(3):1176-85
pubmed: 15528117
PLoS One. 2014 Nov 18;9(11):e112638
pubmed: 25405990
Radiology. 2008 Jan;246(1):214-21
pubmed: 17991785
Arch Neurol. 1999 Jan;56(1):33-9
pubmed: 9923759
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
Neurology. 1994 Nov;44(11):2015-9
pubmed: 7969952
Neuroimage. 2010 Feb 1;49(3):2457-66
pubmed: 19818860
Neuroimage. 2009 Jan 1;44(1):99-111
pubmed: 18848632
J Med Imaging Radiat Oncol. 2018 Feb;62(1):21-31
pubmed: 28432758
Mov Disord. 2017 Jul;32(7):955-971
pubmed: 28500751
Mov Disord. 2004 Feb;19(2):181-9
pubmed: 14978673
J Magn Reson Imaging. 2018 Jan 2;:
pubmed: 29292557
Neurology. 2003 Jun 10;60(11):1766-9
pubmed: 12796528
Neuroradiology. 2000 Sep;42(9):643-7
pubmed: 11071435
Parkinsonism Relat Disord. 2017 Aug;41:31-36
pubmed: 28487107
Neuroradiology. 2012 Jul;54(7):771-80
pubmed: 22160214
Eur Radiol. 2017 Jun;27(6):2665-2675
pubmed: 27761709
Front Neurol. 2018 Aug 28;9:716
pubmed: 30210438
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):696-701
pubmed: 29348302
Neuroimage. 2014 Oct 1;99:498-508
pubmed: 24956065
Trends Cogn Sci. 1998 Sep 1;2(9):348-54
pubmed: 21227231
Neuroinformatics. 2013 Jul;11(3):319-37
pubmed: 23417655
Neuroradiology. 2015 Nov;57(11):1079-91
pubmed: 26253801
Neurobiol Aging. 2012 Dec;33(12):2817-26
pubmed: 22418735
AJNR Am J Neuroradiol. 2009 Sep;30(8):1482-7
pubmed: 19589886
Brain. 2002 Apr;125(Pt 4):861-70
pubmed: 11912118
Mov Disord. 2011 Aug 1;26(9):1752-5
pubmed: 21500281
J Neurol. 2015 Aug;262(8):1850-8
pubmed: 25980906
Neuroimage. 2013 Feb 15;67:298-312
pubmed: 23238430
Radiology. 2013 Jun;267(3):843-50
pubmed: 23329659
Curr Opin Neurol. 2010 Aug;23(4):394-400
pubmed: 20610990
Parkinsonism Relat Disord. 2018 Apr;49:81-87
pubmed: 29463454
Neuroimage. 2012 Jan 2;59(1):286-96
pubmed: 21777683
J Neuropathol Exp Neurol. 2001 Jun;60(6):647-57
pubmed: 11398841
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Mov Disord. 2008 Dec 15;23(16):2370-6
pubmed: 18816803
Neuroimage. 2007 May 1;35(4):1459-72
pubmed: 17379540
Magn Reson Imaging. 1999 Nov;17(9):1269-74
pubmed: 10576712
Neuroradiology. 2012 Sep;54(9):947-55
pubmed: 22274571
Neurology. 2013 Feb 26;80(9):857-64
pubmed: 23439701
MAGMA. 2017 Aug;30(4):317-335
pubmed: 28181027
Brain. 2006 Oct;129(Pt 10):2679-87
pubmed: 16815875
Mov Disord. 2010 Jul 15;25(9):1232-8
pubmed: 20222139
Magn Reson Med. 1996 Dec;36(6):893-906
pubmed: 8946355
Front Pediatr. 2017 Aug 30;5:182
pubmed: 28913326
Curr Neurol Neurosci Rep. 2004 Jul;4(4):296-302
pubmed: 15217544
Neurology. 2005 Feb 22;64(4):675-9
pubmed: 15728291
Neurobiol Aging. 2014 Oct;35(10):2404-10
pubmed: 24786632
Mov Disord. 2011 Feb 1;26(2):256-63
pubmed: 21412832
Neuroimage. 2003 Jul;19(3):1014-32
pubmed: 12880829

Auteurs

Salvatore Nigro (S)

Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.

Maria Giovanna Bianco (MG)

Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.

Gennarina Arabia (G)

Department of Medical and Surgical Sciences, Institute of Neurology, Magna Graecia University, Catanzaro, Italy.

Maurizio Morelli (M)

Department of Medical and Surgical Sciences, Institute of Neurology, Magna Graecia University, Catanzaro, Italy.

Rita Nisticò (R)

Institute of Bioimaging and Molecular Physiology, National Research Council, Catanzaro, Italy.

Fabiana Novellino (F)

Institute of Bioimaging and Molecular Physiology, National Research Council, Catanzaro, Italy.

Maria Salsone (M)

Institute of Bioimaging and Molecular Physiology, National Research Council, Catanzaro, Italy.

Antonio Augimeri (A)

Biotecnomed S.C.aR.L, Catanzaro, Italy.

Aldo Quattrone (A)

Department of Medical and Surgical Sciences, Institute of Neurology, Magna Graecia University, Catanzaro, Italy.
Institute of Bioimaging and Molecular Physiology, National Research Council, Catanzaro, Italy.
Neuroscience Center, Magna Graecia University, Catanzaro, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH